General
Preferred name
ENFLURANE
Synonyms
NSC115944 ()
Ethrane ()
NSC-115944 ()
Efrane ()
NSC 115944 ()
Methylflurether ()
R-E-235CA2 ()
Anesthetic Compound No. 347 ()
Enflurano ()
Compound 347 ()
Ohio 347 ()
Alyrane ()
P&D ID
PD010158
CAS
13838-16-9
Tags
available
drug
Approved by
FDA
First approval
1972
Drug indication
Anaesthesia
Drug Status
withdrawn
approved
vet_approved
Max Phase
4.0
Structure
Probe scores
P&D probe-likeness score
[[ v.score ]]%
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE 29
DESCRIPTION Enflurane is a halogenated ether inhalational anaesthetic, but it is no longer in common use. It is a structural isomer of . (GtoPdb)
DESCRIPTION Enflurane (Efrane), a volatile anaesthetic, is a potent inhibitor of high conductance Ca2+-activated K+ channels of Chara australis. Enflurane is an internal standard in monitoring halogenated volatile anaesthetics by headspace gas chromatography-mass spectrometry. It allows rapid adjustments of anesthesia depth with little change in pulse or respiratory rate. (TargetMol Bioactive Compound Library)
Compound Sets
17
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
CZ-OPENSCREEN Bioactive Library
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP
DrugMAP Approved Drugs
DrugMatrix
Enamine BioReference Compounds
Guide to Pharmacology
JUMP-Target 1 Compound Set
NPC Screening Collection
ReFrame library
TargetMol Bioactive Compound Library
External IDs
33
Properties
(calculated by RDKit )
Molecular Weight
183.97
Hydrogen Bond Acceptors
1
Hydrogen Bond Donors
0
Rotatable Bonds
3
Ring Count
0
Aromatic Ring Count
0
cLogP
2.35
TPSA
9.23
Fraction CSP3
1.0
Chiral centers
1.0
Largest ring
0.0
QED
0.48
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Target
ATP5F1D
Therapeutic Class
Anesthetics
Source data